Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX1 | Q96LB2 | 5/20 | 0.48 |
| ▸ | METAP2 | P50579 | 1/20 | 0.46 |
| ▸ | CCR2 | P41597 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
| ▸ | F2 | P00734 | 7/20 | 0.43 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.42 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6554463 | 0.73 | PPARA (0.52) | METAP2CCR2CYP19A1PPARAKDM4E | |
| SCHEMBL6860332 | 0.70 | CYP19A1 (0.60) | MRGPRX1METAP2CCR2CYP19A1 | |
| SCHEMBL7451126 | 0.68 | MEN1 (0.43) | PPARA | |
| SCHEMBL2616443 | 0.68 | METAP2 (0.62) | METAP2 | |
| SCHEMBL13244238 | 0.67 | TSHR (0.48) | METAP2CYP19A1KDM4E | |
| SCHEMBL9581847 | 0.67 | CYP19A1 (0.50) | MRGPRX1CYP19A1KDM4E | |
| SCHEMBL7579963 | 0.67 | METAP2 (0.69) | METAP2 | |
| Hydrochloric Acid SCHEMBL7922072 | 0.67 | PPARA (0.46) | MRGPRX1PPARAF2KDM4E | |
| SCHEMBL6807990 | 0.66 | HSD17B2 (0.69) | METAP2 | |
| SCHEMBL578654 | 0.66 | FFAR4 (0.68) | METAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5792769-A | POTENT ANTICOAGULANT, ANTIINFLAMMATORY AGENT; TREATMENT/PROPHYLAXIS OF RESPIRATORY SYSTEM DISORDERS, VASCULAR SYSTEM DISORDERS, ANTITUMOR AGENTS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 1998-08-11 | — | — | US | disclosed |